Moleculin Biotech, Inc., (Nasdaq: MBRX) announced it has secured an agreement with Dermin Sp. Zo. O. ("Dermin") to utilize Dermin's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE